1. Home
  2. UFG vs LPCN Comparison

UFG vs LPCN Comparison

Compare UFG & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Uni-Fuels Holdings Limited

UFG

Uni-Fuels Holdings Limited

BUY

Current Price

$0.36

Market Cap

16.2M

Sector

Energy

ML Signal

BUY

Logo Lipocine Inc.

LPCN

Lipocine Inc.

BUY

Current Price

$1.68

Market Cap

18.7M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
UFG
LPCN
Founded
2021
1997
Country
Singapore
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.2M
18.7M
IPO Year
2024
2011

Fundamental Metrics

Financial Performance
Metric
UFG
LPCN
Price
$0.36
$1.68
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $5.00
AVG Volume (30 Days)
251.0K
★ 1.5M
Earning Date
09-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $1,976,677.00
Revenue This Year
$26.00
N/A
Revenue Next Year
N/A
$18.02
P/E Ratio
$211.08
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.36
$1.59
52 Week High
$1.56
$12.37

Technical Indicators

Market Signals
Indicator
UFG
LPCN
Relative Strength Index (RSI) 30.65 30.07
Support Level N/A N/A
Resistance Level $1.02 $2.40
Average True Range (ATR) 0.04 0.19
MACD -0.01 -0.05
Stochastic Oscillator 11.84 5.13

Price Performance

Historical Comparison
UFG
LPCN

About UFG Uni-Fuels Holdings Limited

Uni-Fuels Holdings Ltd is a service provider of marine fuel solutions. It operates on an integrated business model, serving customers through two operating models: sales of marine fuels solutions and brokerage (i.e., acting as an intermediary between marine fuels suppliers and customers for a commission). The various marine fuel products offered by the company include very low sulfur fuel oil, high sulfur fuel oil, marine gas oil, and bio marine fuel. Its customers are mainly shipping companies and other fuel suppliers operating in market sectors such as bulk, tanker, offshore, container, general cargo, tug and barge, car carrier, cruise, yacht, and dredging. Geographically, the company derives maximum revenue from Singapore, and the rest from Malaysia, Hong Kong, China, and other regions.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: